Hawkins (HWKN)
(Delayed Data from NSDQ)
$125.18 USD
+3.96 (3.27%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $125.18 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
F Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$125.18 USD
+3.96 (3.27%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $125.18 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
F Value B Growth D Momentum C VGM
Zacks News
Why Hawkins (HWKN) Might be Well Poised for a Surge
by Zacks Equity Research
Hawkins (HWKN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Hawkins (HWKN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 12.86% and 1.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Hawkins (HWKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hawkins (HWKN) Q4 Earnings and Sales Surpass Estimates
by Zacks Equity Research
Higher consumer demand for health and immunity products drove sales in Hawkins' (HWKN) Health and Nutrition segment in Q4.
Hawkins (HWKN) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 65.38% and 8.36%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Hawkins (HWKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Specialty Chemicals Stocks to Gain From Industry Turnaround
by Kaustav Ghosh
The global specialty chemicals industry seems poised to rebound on the gradual resumption of economic activities worldwide, making it prudent to invest in names like Kraton (KRA) and Hawkins (HWKN)
Hawkins (HWKN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Hawkins (HWKN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Hawkins (HWKN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 20.97% and 5.15%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Is Hawkins (HWKN) a Profitable Stock for Value Investors Now?
by Zacks Equity Research
Let's see if Hawkins (HWKN) stock is a good choice for value-oriented investors right now from multiple angles.
Looking for a Growth Stock? 3 Reasons Why Hawkins (HWKN) is a Solid Choice
by Zacks Equity Research
Hawkins (HWKN) could produce exceptional returns because of its solid growth attributes.
Are Investors Undervaluing Hawkins (HWKN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
This is Why Hawkins (HWKN) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Hawkins (HWKN) have what it takes? Let's find out.
Hawkins (HWKN) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 3.60% and -0.08%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
US Chemical August Output Nudges Up on Manufacturing Strength
by Anindya Barman
U.S. chemical production expanded 0.6% in August as recovery gained steam in the manufacturing sector.
US Specialty Chemical Rebound Continues as August Volume Rises
by Anindya Barman
U.S. specialty chemicals market volumes ticked up 0.5% in August with most segments seeing growth.
5 Chemical Stocks to Snap Up on Global Manufacturing Revival
by Anindya Barman
With China seeing an economic rebound and manufacturing activities are improving around the world, things are looking up for the chemical industry.
US Chemical Output Ticks Up in July on Manufacturing Rebound
by Anindya Barman
U.S. chemical production expanded 0.8% in July as recovery strengthened in the manufacturing sector.
US Specialty Chemical Volumes Expand in July: 4 Top Picks
by Anindya Barman
The rebound in manufacturing activity and continued recovery in the U.S. economy are likely to act as a tailwind for the U.S. specialty chemical industry.
Can Hawkins (HWKN) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Hawkins (HWKN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Hawkins' Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Hawkins.
Looking for a Growth Stock? 3 Reasons Why Hawkins (HWKN) is a Solid Choice
by Zacks Equity Research
Hawkins (HWKN) could produce exceptional returns because of its solid growth attributes.
Hawkins (HWKN) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 11.00% and -6.30%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) to Report Q1 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Hawkins (HWKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Hawkins (HWKN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.